Can Hormonal Therapies for Cancer be Affected by Endocrine Disruptors?
Yes, hormonal therapies used to treat cancers, such as Tamoxifen for breast cancer, can be influenced by endocrine disruptors. These disruptors can interfere with the efficacy of the treatment by either enhancing or diminishing the therapeutic effects, making it crucial for patients to manage their exposure during treatment.
